Phase 3 Narcolepsy Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You are willing and able to understand and follow all the steps and requirements of the trial.
• You have been diagnosed with Narcolepsy Type 1 (NT1), Narcolepsy Type 2 (NT2), or Idiopathic Hypersomnia (IH), and you have already completed the treatment period in a related previous TAK-360 trial.
• You have signed and dated a consent form agreeing to take part before any trial procedures begin.

Who may not be able to join:

• You are pregnant (based on a positive pregnancy test) or are currently breastfeeding.
• You have shown signs of being at risk of suicide, based on specific questions from a standard assessment tool called the Columbia Suicide Severity Rating Scale (confirm with trial site).
• You have developed a new medical condition that causes excessive daytime sleepiness.
• You have developed a stomach or digestive system disease in the last 6 months that could affect how your body absorbs medication.
• You have developed a new history of seizures.
• You have had a significant head injury, as judged by the trial doctor.
• You have developed a history of stroke, a mini-stroke (within the last 5 years), or bleeding in the brain.
• You have developed a history of heart attack, significant heart or coronary artery disease, significant chest pain (angina), significant irregular heart rhythm, or heart failure.
• You have been diagnosed with a significant thyroid condition, known liver problems, or another serious long-term medical condition beyond your sleep disorder.
• You have had a cancer diagnosis in the past 5 years.

Important: Always verify eligibility with the trial site directly before applying.